Cargando…
Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
Background. Recurrent therapeutic failures reported for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) with vancomycin may be due to poor bactericidal activity. Alternative antibacterial approaches using bacteriophages may overcome this limitation. Ob...
Autores principales: | Save, Jonathan, Que, Yok-Ai, Entenza, José, Resch, Grégory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412893/ https://www.ncbi.nlm.nih.gov/pubmed/36016414 http://dx.doi.org/10.3390/v14081792 |
Ejemplares similares
-
Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis
por: Save, Jonathan, et al.
Publicado: (2022) -
Draft Genome Sequence of Methicillin-Resistant Staphylococcus aureus Strain AW7, Isolated from a Patient with Bacteremia
por: Cameron, David R., et al.
Publicado: (2019) -
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis
por: Que, Yok-Ai, et al.
Publicado: (2005) -
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence
por: Oechslin, Frank, et al.
Publicado: (2017) -
Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)